SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : GenVec - GNVC
GNVC 7.1930.0%Jun 26 5:00 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Savant who wrote (30)5/13/2011 12:33:58 PM
From: Gary Mohilner  Read Replies (1) of 106
 
Should GNVC get a partnership for either TNFerade, RSV, or Dengue Fever Vaccines it's very possible that the up front payment could make them cash positive for the year. With the R/S cutting the O/S to 13 million, such a payment could dramatically move the stock.

For now we're still roughly $1 below where we'd been if no R/S had been done, I cannot call it a complete success until at least that much is recaptured without any real news. At this point, however, I'd concede this R/S has been more successful then about 90% of the one's I've seen. I believe the company has a viable business plan, now they must execute it.

Gary
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext